Cardiol Therapeutics (CRDL) Earnings Date & Reports

Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CRDL is expected to report earnings to fall 10.93% to -6 cents per share on August 17

Cardiol Therapeutics CRDL Stock Earnings Reports

Q2'26

Est.

$-0.07

Q1'26

Est.

$-0.07

Q4'25

Beat

by $0.03

Q3'25

Missed

by $0.01

Q2'25

Beat

by $0.03

The last earnings report on May 11 showed earnings per share of -7 cents, beating the estimate of -7 cents. With 134.27K shares outstanding, the current market capitalization sits at 151.67M.

View a ticker or compare two or three

Compare

CRDL

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for CRDL

A.I. Advisor